Status:
UNKNOWN
Methylphenidate Treatment Response Study of Genetic Polymorphism in Attention Deficit Hyperactivity Disorder(ADHD)
Lead Sponsor:
Seoul National University Hospital
Collaborating Sponsors:
Korea Health Industry Development Institute
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
6-18 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether norepinephrine gene polymorphism affect to treatment response in ADHD
Eligibility Criteria
Inclusion
- diagnosis made by DSM-IV and K-SADS-PL
- IQ \> 71
Exclusion
- genetic disorder
- history of acquired brain injury
- seizure disorder
- other neurologic disorder
- mental disorder, pervasive developmental disorder
- obsessive-Compulsive disorder
- communication disorder
- learning disorder
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00862108
Start Date
September 1 2008
End Date
March 1 2010
Last Update
September 22 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110-769